<unk>  has a number of uses in medicine including in the treatment of: * Obsessive–compulsive disorder (OCD) which is its only U.S. -labeled indication. Other regulatory agencies (such as the TGA of Australia and the MHRA of the UK) have also approved<unk>  for this indication. * Major depressive disorder (MDD) a popular off-label use in the US. It is approved by the Australian TGA and the United Kingdom MHRA for this indication. Some have suggested the possible superior efficacy of<unk>  compared to other antidepressants in the treatment of MDD, although at the current time the evidence is insufficient to adequately substantiate this claim. * Panic disorder with or without agoraphobia. * Body dysmorphic disorder * Cataplexy associated with narcolepsy. Which is a TGA and MHRA-labeled indication for<unk> . * Premature ejaculation * Depersonalization disorder * Chronic pain with or without organic disease, particularly headache of the tension type. * Sleep paralysis, with or without narcolepsy * Enuresis (involuntary urinating in sleep) in children. The effect may not be sustained following treatment, and alarm therapy may be more effective in both the short-term and the long-term. Combining a tricyclic (such as<unk>  with anticholinergic medication, may be more effective for treating enuresis than the tricyclic alone. * Trichotillomania In a meta-analysis of various trials involving fluoxetine (Prozac), fluvoxamine (Luvox), and sertraline (Zoloft) to test their relative efficacies in treating OCD,<unk>  was found to be the most effective.
Clomipramine
Trimipramine
Desipramine
Carpipramine
Imipramine
Sertraline
Citalopram
Escitalopram